How lipidomics provides new insight into drug discovery

Bibliography

• Lamaziere A, Wolf C, Quinn PJ. Application of Lipidomics to assess lipogenesis in drug development and pre-clinical trials. Curr Pharm Biotech 2012;13:736-45
   PubMed Web of Science ®Google Scholar
• Murphy S, Nicolaou A. Lipidomics applications in health, disease and nutrition research. Mol Nutr Food Res 2013;57:1336-46
   PubMed Web of Science ®Google Scholar
• Gonzalez-Covarrubias V. Lipidomics in longevity and healthy aging. Biogerontology 2013;14:663-72
   PubMed Web of Science ®Google Scholar
• Lam SM, Shui G. Lipidomics as a principal tool for advancing biomedical research. J Genet Genomics 2013;40:375-90
   PubMed Web of Science ®Google Scholar
• Smilowitz JT, Zivkovic AM, Wan Y-JY, et al. Nutritional lipidomics: molecular metabolism, analytics, and diagnostics. Mol Nutr Food Res 2013;57:1319-35
   PubMed Web of Science ®Google Scholar
• Watts GF, Castelluccio C, Riceevans C, et al. Plasma Coenzyme-Q (ubiquinone) concentrations in patients treated with symvastatin. J Clin Pathol 1993;46:1055-7
   PubMed Web of Science ®Google Scholar
• Reiner Ž. Statins in the primary prevention of cardiovascular disease. Nat Rev Cardiol 2013;10:453-64
   PubMed Web of Science ®Google Scholar
• Liu Y, Su Q, Li L. Efficacy of short-term high-dose Atorvastatin pretreatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention: a meta-analysis of nine randomized controlled trials. Clin Cardiol 2013;36:E41-8
   PubMed Web of Science ®Google Scholar
• Ng TW, Khan AA, Meikle PJ. Investigating the pathogenesis and risk of Type 2 diabetes: clinical applications of metabolomics. Clin Lipidol 2012;7:641-59
   Web of Science ®Google Scholar
• Kukorelli G, Reisinger P, Pinke G. ACCase inhibitor herbicides – selectivity, weed resistance and fitness cost: a review. Int J Pest Manag 2013;59:165-73
   Web of Science ®Google Scholar
• Baenke F, Peck B, Miess H, et al. Hooked on fat: the role of lipid synthesis in cancer metabolism and tumour development. Dis Model Mech 2013;6:1353-63
   PubMed Web of Science ®Google Scholar
• Zhang T, Saghatelian A. Emerging roles of lipids in BCL-2 family-regulated apoptosis. Biochim Biophys Acta 2013;1831:1542-54
   PubMed Web of Science ®Google Scholar
• Kim SW, Cho KJ, Lee BI. Compensatory actions of orexinergic neurons in the lateral hypothalamus during metabolic or cortical challenges may enable the coupling of metabolic dysfunction and cortical dysfunction. Med Hypotheses 2013;80:520-6
   PubMed Web of Science ®Google Scholar
• Pénicaud L, Meillon S, Brondel L. Leptin and the central control of feeding behavior. Biochimie 2012;94:2069-74
   PubMed Web of Science ®Google Scholar
• Nedvídková J, Smitka K, Kopský V, et al. Adiponectin, an adipocyte-derived protein. Physiol Res 2005;54:133-40
   PubMed Web of Science ®Google Scholar
• Lopaschuk GD, Ussher JR, Jaswal JS. Targeting Intermediary Metabolism in the hypothalamus as a mechanism to regulate apetite. Pharmacol Rev 2010;62:237-64
   PubMed Web of Science ®Google Scholar
• Orsak T, Smith TL, Eckert D, et al. Revealing the allosterome: systematic identification of metabolite-protein interactions. Biochemistry 2012;51:225-32
   PubMed Web of Science ®Google Scholar
• Gao S, Moran TH, Lopaschuk GD, et al. Hypothalamic malonyl-CoA and the control of food intake. Physiol Behav 2013;122C:17-24
   Google Scholar
• Ramírez S, Martins L, Jacas J, et al. Hypothalamic ceramide levels regulated by CPT1C mediate the orexigenic effect of ghrelin. Diabetes 2013;62:2329-37
   PubMed Web of Science ®Google Scholar
• Williams SCP. Link between obesity and cancer. Proc Natl Acad Sci USA 2013;110:8753-4
   PubMed Web of Science ®Google Scholar
• Louie SM, Roberts LS, Nomura DK. Mechanisms linking obesity and cancer. Biochim Biophys Acta 2013;1831:1499-508
   PubMed Web of Science ®Google Scholar
• Nieman KM, Romero IL, Van Houten B, et al. Adipose tissue and adipocytes support tumourigenesis and metastasis. Biochim Biophys Acta 2013;1831:1533-41
   PubMed Web of Science ®Google Scholar
• Kochuparambil ST, Al-Husein B, Goc A, et al. Anticancer efficacy of simvastatin on prostate cancer cells and tumour xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression. J Pharmacol Exp Ther 2011;336:496-505
   PubMed Web of Science ®Google Scholar
• Relja B, Meder F, Wang M, et al. Simvastatin modulates the adhesion and growth of hepatocellular carcinoma cells via decrease of integrin expression and ROCK. Int J Oncol 2011;38:879-85
   PubMed Web of Science ®Google Scholar
• Relja B, Meder F, Wilhelm K, et al. Simvastatin inhibits cell growth and induces apoptosis and G0/G1 cell cycle arrest in hepatic cancer cells. Int J Mol Med 2010;26:735-41
   PubMed Web of Science ®Google Scholar
• Saito A, Saito N, Mol W, et al. Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res 2008;18:85-94
   PubMed Web of Science ®Google Scholar
• Yu X, Pan Y, Ma H, et al. Simvastatin inhibits proliferation and induces apoptosis in human lung cancer cells. Oncol Res 2013;20:351-7
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ, Lum JJ, Hatzivassiliou G, et al. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008;7:11-20
   PubMed Web of Science ®Google Scholar
• Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer 2007;7:763-77
   PubMed Web of Science ®Google Scholar
• Louie SM, Roberts LS, Mulvihill MM, et al. Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids. Biochim Biophys Acta 2013;1831:1566-72
   PubMed Web of Science ®Google Scholar
• Mason P, Liang B, Li L, et al. SCD1 inhibition causes cancer cell death by depleting mono-unsaturated fatty acids. PLoS One 2012;7:e33823
   PubMedGoogle Scholar
• Reske SN, Blumstein NM, Neumaier B, et al. Imaging Prostate Cancer with 11C-choline PET/CT. J Nucl Med 2006;47:1249-54
   PubMed Web of Science ®Google Scholar
• Chu CT, Ji J, Dagda RK, et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol 2013;15:1197-205
   PubMed Web of Science ®Google Scholar
• Tyurina YY, Tyurin VA, Zhao Q, et al. Oxidation of phosphatidylserine: a mechanism for plasma membrane phospholipid scrambling during apoptosis? Biochem Biophys Res Commun 2004;324:1059-64
   PubMed Web of Science ®Google Scholar
• Nagaraju GP, Sharma D. Anti-cancer role of SPARC, an inhibitor of adipogenesis. Cancer Treat Rev 2011;37:559-66
   PubMed Web of Science ®Google Scholar
• Tai IT, Tang MJ. SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat 2008;11:231-46
   PubMed Web of Science ®Google Scholar
• Yardley DA nab-Paclitaxel mechanisms of action and delivery. J Control Release 2013;170:365-72
   PubMed Web of Science ®Google Scholar
• Heinemann V, Reni M, Ychou M, et al. Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies. Cancer Treat Rev 2014;40:118-28
   PubMed Web of Science ®Google Scholar
• Weiss L, Hoffmann GE, Schreiber R, et al. Fatty-acid biosynthesis in Man, a pathway of minor importance. purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol Chem Hoppe Seyler 1986;367:905-12
   PubMed Web of Science ®Google Scholar
• Milgraum LZ, Witters LA, Pasternack GR, et al. Enzymes of the fatty acid synthesis pathway are highly expressed in in situ breast carcinoma. Clin Cancer Res 1997;3:2115-20
   PubMed Web of Science ®Google Scholar
• Wein House S, Warburg O, Burk D, et al. On Respiratory Impairment in Cancer Cells. Science 1956;124:267-72
   PubMed Web of Science ®Google Scholar
• Macintyre AN, Rathmell JC. Activated lymphocytes as a metabolic model for carcinogenesis. Cancer Metab 2013;1:5
   PubMedGoogle Scholar
• Holder AM, Gonzalez-Angulo AM, Chen H, et al. High stearoyl-CoA desaturase 1 expression is associated with shorter survival in breast cancer patients. Breast Cancer Res Treat 2013;137:319-27
   PubMed Web of Science ®Google Scholar
• Szutowicz A, Kwiatkowski J, Angielski S. Lipogenetic and glycolytic enzyme activities in carcinoma and nonmalignant diseases of the human breast. Br J Cancer 1979;39:681-7
   PubMed Web of Science ®Google Scholar
• Wolf G. Nutritional and hormonal regulation of fatty acid synthase. Nutr Rev 1996;54:122-3
   PubMed Web of Science ®Google Scholar
• Eissing L, Scherer T, Tödter K, et al. De novo lipogenesis in human fat and liver is linked to ChREBP-beta and metabolic health. Nat Commun 2013;4:1528
   PubMed Web of Science ®Google Scholar
• Berggreen C, Gormand A, Omar B, et al. Protein kinase B activity is required for the effects of insulin on lipid metabolism in adipocytes. Am J Physiol Endocrinol Metab 2009;296:E635-46
   PubMed Web of Science ®Google Scholar
• Bost F, Aouadi M, Caron L, et al. The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 2005;54:402-11
   PubMed Web of Science ®Google Scholar
• Cheng Y, Chen G, Hong L, et al. How does hypoxia inducible factor-1α participate in enhancing the glycolysis activity in cervical cancer? Ann Diagn Pathol 2013;17:305-11
   PubMed Web of Science ®Google Scholar
• Lu S, Archer MC. Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells. Int J Cancer 2010;126:416-25
   PubMed Web of Science ®Google Scholar
• Jiang P, Du W, Mancuso A, et al. Reciprocal regulation of p53 and malic enzymes modulates metabolism and senescence. Nature 2013;493:689-93
   PubMed Web of Science ®Google Scholar
• Shao Y, Wall EH, McFadden TB, et al. Lactogenic hormones stimulate expression of lipogenic genes but not glucose transporters in bovine mammary gland. Domest Anim Endocrinol 2013;44:57-69
   PubMed Web of Science ®Google Scholar
• Li W, Tai Y, Zhou J, et al. Repression of endometrial tumour growth by targeting SREBP1 and lipogenesis. Cell Cycle 2012;11:2348-58
   PubMed Web of Science ®Google Scholar
• Arunakaran J, Balasubramanian K, Srinivasan N, et al. Effects of androgens, prolactin and bromocriptine on seminal vesicular enzymes of the pyruvate malate cycle involved in lipogenesis in castrated mature monkeys, Macaca radiata. Int J Androl 1988;11:133-9
   PubMed Web of Science ®Google Scholar
• Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol 2004;22:360-6
   PubMed Web of Science ®Google Scholar
• Provost PR, Boucher E, Tremblay Y. Glucocorticoid metabolism in the developing lung: adrenal-like synthesis pathway. J Steroid Biochem Mol Biol 2013;138:72-80
   PubMed Web of Science ®Google Scholar
• López M, Lage R, Saha AK, et al. Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 2008;7:389-99
   PubMed Web of Science ®Google Scholar
• Wang J, Hudson R, Sintim HO. Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs. Future Med Chem 2012;4:1113-51
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Supuran CT, Carta F. Antiobesity carbonic anhydrase inhibitors: a literature and patent review. Expert Opin Ther Pat 2013;23:725-35
   PubMed Web of Science ®Google Scholar
• Monti SM, Supuran CT, De Simone G. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013). Expert Opin Ther Pat 2013;23:737-49
   PubMed Web of Science ®Google Scholar
• Wang C, Rajput S, Watabe K, et al. Acetyl-CoA carboxylase-a as a novel target for cancer therapy. Front Biosci (Schol Ed) 2010;2:515-26
   PubMedGoogle Scholar
• Corbett JW. Review of recent acetyl-CoA carboxylase inhibitor patents: mid-2007-2008. Expert Opin Ther Pat 2009;19:943-56
   PubMed Web of Science ®Google Scholar
• Liu G. Stearoyl-CoA desaturase inhibitors: update on patented compounds. Expert Opin Ther Pat 2009;19:1169-91
   PubMed Web of Science ®Google Scholar
• Huang C, Lee S, Lin C, et al. Co-treatment with quercetin and 1,2,3,4,6,-penta-O-galloyl-beta-D-glucose causes cell cycle arrest and apoptosis in human breast cancer MDA-MB-231 and AU565 Cells. J Agric Food Chem 2013;61:6430-45
   PubMed Web of Science ®Google Scholar
• Oliveras G, Blancafort A, Urruticoechea A, et al. Novel anti-fatty acid synthase compounds with anti-cancer activity in HER2+ breast cancer. Ann NY Acad Sci 2010;1210:86-92
   PubMed Web of Science ®Google Scholar
• Harwood HJ. Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition. Expert Opin Ther Targets 2005;9:267-81
   PubMed Web of Science ®Google Scholar
• Jump DB, Torres-Gonzalez M, Olson LK. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem Pharmacol 2011;81:649-60
   PubMed Web of Science ®Google Scholar
• O'Connor SE, Richardson C, Trescher WH, et al. The Ketogenic Diet for the Treatment of Pediatric Status Epilepticus. Pediatr Neurol 2014;50:101-3
   PubMed Web of Science ®Google Scholar
• Kossoff EH, Hartman AL. Ketogenic diets: new advances for metabolism-based therapies. Curr Opin Neurol 2012;25:173-8
   PubMed Web of Science ®Google Scholar
• Issandou M, Bouillot A, Brusq JM, et al. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models. Eur J Pharmacol 2009;618:28-36
   PubMed Web of Science ®Google Scholar
• Kurikawa N, Takagi T, Wakimoto S, et al. A novel inhibitor of stearoyl-CoA desaturase-1 attenuates hepatic lipid accumulation, liver injury and inflammation in model of nonalcoholic steatohepatitis. Biol Pharm Bull 2013;36:259-67
   PubMed Web of Science ®Google Scholar
• Binczek E, Jenke B, Holz B, et al. Obesity resistance of the stearoyl-CoA desaturase-deficient (scd1-/-) mouse results from disruption of the epidermal lipid barrier and adaptive thermoregulation. Biol Chem 2007;388:405-18
   PubMed Web of Science ®Google Scholar
• Miyazaki M, Man WC, Ntambi JM. Targeted Disruption of Stearoyl-CoA Desaturase1 Gene in Mice Causes Atrophy of Sebaceous and Meibomian Glands and Depletion of Wax Esters in the Eyelid. J Nutr 2001;131:2260-8
   PubMed Web of Science ®Google Scholar
• Tong L. Structure and function of biotin-dependent carboxylases. Cell Mol Life Sci 2013;70:863-91
   PubMed Web of Science ®Google Scholar
• Cronan JE, Waldrop GL. Multi-subunit acetyl-CoA carboxylases. Prog Lipid Res 2002;41:407-35
   PubMed Web of Science ®Google Scholar
• Jang S, Marjanovic J, Gornicki P. Resistance to herbicides caused by single amino acid mutations in acetyl-CoA carboxylase in resistant populations of grassy weeds. New Phytol 2013;197:1110-16
   PubMed Web of Science ®Google Scholar
• Yu Q, Ahmad-Hamdani MS, Han H, et al. Herbicide resistance-endowing ACCase gene mutations in hexaploid wild oat (Avena fatua): insights into resistance evolution in a hexaploid species. Heredity (Edinb) 2013;110:220-31
   PubMed Web of Science ®Google Scholar
• Schwenk RW, Holloway GP, Luiken JJFP, et al. Fatty acid transport across the cell membrane: regulation by fatty acid transporters. Prostaglandins Leukot Essent Fatty Acids 2010;82:149-54
   PubMed Web of Science ®Google Scholar
• Brown JM, Chung S, Sawyer JK, et al. Inhibition of stearoyl-coenzyme A desaturase 1 dissociates insulin resistance and obesity from atherosclerosis. Circulation 2008;118:1467-75
   PubMed Web of Science ®Google Scholar
• Emken EA. Stable isotope approaches, applications, and issues related to polyunsaturated fatty acid metabolism studies. Lipids 2001;36:965-73
   PubMed Web of Science ®Google Scholar
• Chen JL, Peacock E, Samady W, et al. Physiologic and pharmacologic factors influencing glyceroneogenic contribution to triacylglyceride glycerol measured by mass isotopomer distribution analysis. J Biol Chem 2005;280:25396-402
   PubMed Web of Science ®Google Scholar
• Murphy EJ. Stable isotope methods for the in vivo measurement of lipogenesis and triglyceride metabolism. J Anim Sci 2006;84:E94-104
   PubMedGoogle Scholar
• Wenk MR. Lipidomics: new tools and applications. Cell 2010;143:888-95
   PubMed Web of Science ®Google Scholar
• Meikle PJ, Wong G, Barlow CK, et al. Plasma lipid profiling shows similar associations with prediabetes and type 2 diabetes. PLoS One 2013;8:e74341
   PubMed Web of Science ®Google Scholar
• Cao H, Gerhold K, Mayers JR, et al. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008;134:933-44
   PubMed Web of Science ®Google Scholar
• Lamaziere A, Wolf C, Barbe U, et al. Lipidomics of hepatic lipogenesis inhibition by omega 3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2013;88:149-54
   PubMed Web of Science ®Google Scholar
• Roux C, Wolf C, Mulliez N, et al. Role of cholesterol in embryonic development. Am J Clin Nutr 2000;71:1270S-9S
   PubMed Web of Science ®Google Scholar
• Wolf G. Nutritional and hormonal regulation of fatty acid synthase. Nutr Rev 1996;54:122-3
   PubMed Web of Science ®Google Scholar
• Bouwens M, Grootte Bromhaar M, Jansen J, et al. Postprandial dietary lipid-specific effects on human peripheral blood mononuclear cell gene expression profiles. Am J Clin Nutr 2010;91:208-17
   PubMed Web of Science ®Google Scholar
• Dolores Mayas M, Isabel Queipo-Ortuño M, Clemente-Postigo M, et al. Influence of a fat overload on lipogenic regulators in metabolic syndrome patients. Br J Nutr 2011;105:895-901
   PubMed Web of Science ®Google Scholar
• Moon YS, Latasa M-J, Griffin MJ, et al. Suppression of fatty acid synthase promoter by polyunsaturated fatty acids. J Lipid Res 2002;43:691-8
   PubMed Web of Science ®Google Scholar
• Gomez FE, Bauman DE, Ntambi JM, et al. Effects of sterculic acid on stearoyl-CoA desaturase in differentiating 3T3-L1 adipocytes. Biochem Biophys Res Commun 2003;300:316-26
   PubMed Web of Science ®Google Scholar
• Khoo DE, Fermor B, Miller J, et al. Manipulation of body fat composition with sterculic acid can inhibit mammary carcinomas in vivo. Br J Cancer 1991;63:97-101
   PubMed Web of Science ®Google Scholar
• Nagaraju GPC, Sharma D. Anti-cancer role of SPARC, an inhibitor of adipogenesis. Cancer Treat Rev 2011;37:559-66
   PubMed Web of Science ®Google Scholar
• Tai IT, Tang MJ. SPARC in cancer biology: its role in cancer progression and potential for therapy. Drug Resist Updat 2008;11:231-46
   PubMed Web of Science ®Google Scholar
• Jump DB, Torres-Gonzalez M, Olson LK. Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation. Biochem Pharmacol 2011;81:649-60
   PubMed Web of Science ®Google Scholar
• Wang Y, Wong RHF, Tang T, et al. Phosphorylation and recruitment of BAF60c in chromatin remodeling for lipogenesis in response to insulin. Mol Cell 2013;49:283-97
   PubMed Web of Science ®Google Scholar
• Satoshi O. Cerulenin. Methods Enzymol 1981;72:520-32
   PubMedGoogle Scholar
• Wong RHF, Chang I, Hudak CSS, et al. A role of DNA-PK for the metabolic gene regulation in response to insulin. Cell 2009;136:1056-72
   PubMed Web of Science ®Google Scholar
• Furumai T, Suzuki M. Studies on the biosynthesis of basic 16-membered macrolide antibiotics, platenomycins. II. Production isolation and structures of 3-O-propionyl-5-O-mycaminosyl platenolides I and II, 9-dehydro demycarosyl platenomycin and demycarosyl platenomycin. J Antibiot (Tokyo) 1975;28:775-82
   PubMed Web of Science ®Google Scholar
• Christie WW, Hunter ML, Clegg RA. The effects of cerulenin on lipid metabolism in vitro in cellular preparations from the rat. Biochim Biophys Acta 1981;666:284-90
   PubMed Web of Science ®Google Scholar
• Weaver KL, Ivester P, Seeds M, et al. Effect of dietary fatty acids on inflammatory gene expression in healthy humans. J Biol Chem 2009;284:15400-7
   PubMed Web of Science ®Google Scholar
• José AAFB V, Gama MAS, Lanna DDP. Effects of trans-10, cis-12 conjugated linoleic acid on gene expression and lipid metabolism of adipose tissue of growing pigs. Genet Mol Res 2008;7:284-94
   PubMed Web of Science ®Google Scholar
• Brown JM, Rudel LL. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol 2010;21:192-7
   PubMed Web of Science ®Google Scholar
• Wang J, Soisson SM, Young K, et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 2006;441:358-61
   PubMed Web of Science ®Google Scholar
• Vitale RM, Pedone C, Amodeo P, et al. Molecular modeling study for the binding of zonisamide and topiramate to the human mitochondrial carbonic anhydrase isoform VA. Bioorg Med Chem 2007;15:4152-8
   PubMed Web of Science ®Google Scholar
• Griffith DA, Dow RL, Huard K, et al. Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structure. J Med Chem 2013;56:7110-19
   PubMed Web of Science ®Google Scholar
• Pemble CW, Johnson LC, Kridel SJ, et al. Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat. Nat Struct Mol Biol 2007;14:704-9
   PubMed Web of Science ®Google Scholar
• Kridel S, Lowther W, Pemble CW. Fatty acid synthase inhibitors: new directions for oncology. Expert Opin Investig Drugs 2007;16:1817-30
   PubMed Web of Science ®Google Scholar
• Sul HS, Wong RHF. US0275699A1; 2011
   Google Scholar
• Griffin MJ, Wong RHF, Pandya N, et al. Direct interaction between USF and SREBP-1c mediates synergistic activation of the fatty-acid synthase promoter. J Biol Chem 2007;282:5453-67
   PubMed Web of Science ®Google Scholar
• McCune SA, Harris RA. Mechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis. J Biol Chem 1979;254:10095-101
   PubMed Web of Science ®Google Scholar
• Zhao H, Serby MD, Smith HT, et al. Discovery of 1-(4-phenoxypiperidin-1-yl)-2-arylaminoethanone stearoyl-CoA desaturase 1 inhibitors. Bioorg Med Chem Lett 2007;17:3388-91
   PubMed Web of Science ®Google Scholar
• Scozzafava A, Supuran CT, Carta F. Antiobesity carbonic anhydrase inhibitors: a literature and patent review. Expert Opin Ther Pat 2013;23:725-35
   PubMed Web of Science ®Google Scholar
• Wang J, Soisson SM, Young K, et al. Platensimycin is a selective FabF inhibitor with potent antibiotic properties. Nature 2006;441:358-61
   PubMed Web of Science ®Google Scholar
• Price AC, Choi KH, Heath RJ, et al. Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism. J Biol Chem 2001;276:6551-9
   PubMed Web of Science ®Google Scholar
• Sanna V, Pintus G, Roggio AM, et al. Targeted biocompatible nanoparticles for the delivery of (-)-epigallocatechin 3-gallate to prostate cancer cells. J Med Chem 2011;54:1321-32
   PubMed Web of Science ®Google Scholar
• McFadden JM, Medghalchi SM, Thupari JN, et al. Application of a flexible synthesis of (5R)-thiolactomycin to develop new inhibitors of type I fatty acid synthase. J Med Chem 2005;48:946-61
   PubMed Web of Science ®Google Scholar
• Makowski K, Mera P, Paredes D, et al. Differential pharmacologic properties of the two C75 enantiomers:(+)-C75 is a strong anorectic drug; (-)-C75 has antitumor activity. Chirality 2013;25:281-87
   PubMed Web of Science ®Google Scholar
• Ortinau LC, Nickelson KJ, Stromsdorfer KL, et al. Sterculic oil, a natural inhibitor of SCD1, improves the metabolic state of obese OLETF rats. Obesity 2013;21:344-52
   PubMed Web of Science ®Google Scholar
• Harwood HJ, Petras SF, Shelly LD, et al. Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals. J Biol Chem 2003;278:37099-111
   PubMed Web of Science ®Google Scholar
• Parker RA, Kariya T, Grisar JM, et al. 5-(Tetradecyloxy)-2-furancarboxylic acid and related hypolipidemic fatty acid-like alkyloxyarylcarboxylic acids. J Med Chem 1977;20:781-91
   PubMed Web of Science ®Google Scholar
• Rivkin AI, Kim YR, Goulet MT, et al. 3-Aryl-4-hydroxyquinolin-2(1H)-one derivatives as type I fatty acid synthase inhibitors. Bioorg Med Chem Lett 2006;16:4620-3
   PubMed Web of Science ®Google Scholar
• Wu MI, Singh SB, Wang J, et al. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc Natl Acad Sci USA 2011;108:5378-83
   PubMed Web of Science ®Google Scholar
• Kuhajda FP, Pizer ES, Li JN, et al. Synthesis and antitumor activity of an inhibitor of fatty acid synthase. Proc Natl Acad Sci USA 2000;97:3450-4
   PubMed Web of Science ®Google Scholar
• Pizer ES, Thupari J, Han WF, et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res 2000;60:213-18
   PubMed Web of Science ®Google Scholar